These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 1997182

  • 21. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
    Rosenberg MC, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner DD, Friedman HS.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6917-22. PubMed ID: 2582434
    [Abstract] [Full Text] [Related]

  • 22. In-transit melanoma: the role of alkylating-agent resistance in regional therapy.
    Grubbs EG, Abdel-Wahab O, Cheng TY, Abdel-Wahab Z, Peterson B, Pruitt SK, Colvin OM, Friedman HS, Tyler DS.
    J Am Coll Surg; 2004 Sep 15; 199(3):419-27. PubMed ID: 15325612
    [Abstract] [Full Text] [Related]

  • 23. Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro.
    Barranco SC, Townsend CM, Weintraub B, Beasley EG, MacLean KK, Shaeffer J, Liu NH, Schellenberg K.
    Cancer Res; 1990 Jun 15; 50(12):3614-8. PubMed ID: 2340510
    [Abstract] [Full Text] [Related]

  • 24. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q, Bianchi P, Bezwoda WR.
    Anticancer Res; 2000 Jun 15; 20(4):2561-8. PubMed ID: 10953327
    [Abstract] [Full Text] [Related]

  • 25. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells.
    Smith MT, Evans CG, Doane-Setzer P, Castro VM, Tahir MK, Mannervik B.
    Cancer Res; 1989 May 15; 49(10):2621-5. PubMed ID: 2713846
    [Abstract] [Full Text] [Related]

  • 26. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
    Ho SB, Yan PS, Dahiya R, Neuschwander-Tetri BA, Basbaum C, Kim YS.
    J Cell Physiol; 1994 Aug 15; 160(2):213-26. PubMed ID: 7913708
    [Abstract] [Full Text] [Related]

  • 27. Overexpression of glutathione-S-transferase, MGSTII, confers resistance to busulfan and melphalan.
    Harkey MA, Czerwinski M, Slattery J, Kiem HP.
    Cancer Invest; 2005 Aug 15; 23(1):19-25. PubMed ID: 15779864
    [Abstract] [Full Text] [Related]

  • 28. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W, Liu G, Zheng J.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):61-7. PubMed ID: 17509556
    [Abstract] [Full Text] [Related]

  • 29. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
    Green JA, Vistica DT, Young RC, Hamilton TC, Rogan AM, Ozols RF.
    Cancer Res; 1984 Nov 30; 44(11):5427-31. PubMed ID: 6488194
    [Abstract] [Full Text] [Related]

  • 30. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
    Caffrey PB, Zhang Y, Frenkel GD.
    Anticancer Res; 1998 Nov 30; 18(4C):3021-5. PubMed ID: 9713503
    [Abstract] [Full Text] [Related]

  • 31. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E, Teicher BA, Holden SA, Cathcart KN, Wang YY.
    Cancer Res; 1988 Nov 15; 48(22):6417-23. PubMed ID: 3180059
    [Abstract] [Full Text] [Related]

  • 32. Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycin.
    Tsuruo T, Hamilton TC, Louie KG, Behrens BC, Young RC, Ozols RF.
    Jpn J Cancer Res; 1986 Sep 15; 77(9):941-5. PubMed ID: 2429947
    [Abstract] [Full Text] [Related]

  • 33. [Changes in glutathione-S-transferase activity during induction of resistance of leukemia P 388 and Ehrlich ascitic tumor cells to doxorubicin].
    Donenko FV, Kabieva AO, Borovkova NB, Moroz LV.
    Biull Eksp Biol Med; 1991 Aug 15; 112(8):188-90. PubMed ID: 1786387
    [Abstract] [Full Text] [Related]

  • 34. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.
    Hospers GA, Mulder NH, de Jong B, de Ley L, Uges DR, Fichtinger-Schepman AM, Scheper RJ, de Vries EG.
    Cancer Res; 1988 Dec 01; 48(23):6803-7. PubMed ID: 2846161
    [Abstract] [Full Text] [Related]

  • 35. Enhanced glutathione peroxidase expression protects cells from hydroperoxides but not from radiation or doxorubicin.
    Liebmann J, Fisher J, Lipschultz C, Kuno R, Kaufman DC.
    Cancer Res; 1995 Oct 01; 55(19):4465-70. PubMed ID: 7671261
    [Abstract] [Full Text] [Related]

  • 36. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
    Kotoh S, Naito S, Yokomizo A, Kumazawa J, Asakuno K, Kohno K, Kuwano M.
    Cancer Res; 1994 Jun 15; 54(12):3248-52. PubMed ID: 8205547
    [Abstract] [Full Text] [Related]

  • 37. Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines.
    Ali-Osman F, Stein DE, Renwick A.
    Cancer Res; 1990 Nov 01; 50(21):6976-80. PubMed ID: 2208164
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line.
    Meijer C, Mulder NH, Timmer-Bosscha H, Zijlstra JG, de Vries EG.
    Cancer Res; 1987 Sep 01; 47(17):4613-7. PubMed ID: 3040227
    [Abstract] [Full Text] [Related]

  • 40. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance.
    Sinha BK, Mimnaugh EG, Rajagopalan S, Myers CE.
    Cancer Res; 1989 Jul 15; 49(14):3844-8. PubMed ID: 2544260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.